CA1297788C - Treatment of aids virus with recombinant human alpha interferon - Google Patents

Treatment of aids virus with recombinant human alpha interferon

Info

Publication number
CA1297788C
CA1297788C CA000549813A CA549813A CA1297788C CA 1297788 C CA1297788 C CA 1297788C CA 000549813 A CA000549813 A CA 000549813A CA 549813 A CA549813 A CA 549813A CA 1297788 C CA1297788 C CA 1297788C
Authority
CA
Canada
Prior art keywords
recombinant human
interferon
htlv
iii
interferon alfa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000549813A
Other languages
English (en)
French (fr)
Inventor
Judith Feinberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp & Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25446188&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA1297788(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of CA1297788C publication Critical patent/CA1297788C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA000549813A 1986-10-22 1987-10-21 Treatment of aids virus with recombinant human alpha interferon Expired - Lifetime CA1297788C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92192286A 1986-10-22 1986-10-22
US921,922 1986-10-22

Publications (1)

Publication Number Publication Date
CA1297788C true CA1297788C (en) 1992-03-24

Family

ID=25446188

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000549813A Expired - Lifetime CA1297788C (en) 1986-10-22 1987-10-21 Treatment of aids virus with recombinant human alpha interferon

Country Status (8)

Country Link
EP (1) EP0266940B1 (cg-RX-API-DMAC10.html)
JP (1) JPS63104929A (cg-RX-API-DMAC10.html)
AT (1) ATE83381T1 (cg-RX-API-DMAC10.html)
CA (1) CA1297788C (cg-RX-API-DMAC10.html)
DE (1) DE3783122T2 (cg-RX-API-DMAC10.html)
ES (1) ES2052579T3 (cg-RX-API-DMAC10.html)
GR (1) GR3006999T3 (cg-RX-API-DMAC10.html)
OA (1) OA08768A (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT99837A (pt) * 1990-12-21 1992-12-31 Schering Corp Processo para a preparacao de composicoes farmaceuticas contendo interferao alfa e metodo para administracao de interferao alfa por inalacao oral para tratar asma e doencas pulmonares proliferativas nao malignas
MX9307733A (es) * 1992-12-23 1994-06-30 Schering Corp Restauracion de la funcion inmunologica en pacientes asintomaticos de vih-positivo.
FR2713657B1 (fr) * 1993-12-13 1996-03-01 Transgene Sa Nouveaux vecteurs pour le traitement du sida.
PT2294066E (pt) 2008-04-28 2014-11-21 Janssen Pharmaceutica Nv Benzoimidazoles como inibidores da prolil-hidroxilase
ES2818977T3 (es) 2011-10-25 2021-04-14 Janssen Pharmaceutica Nv Método para obtener cristales de sal de meglumina de ácido 1-(5,6-dicloro-1H-benzo[d]imidazol-2-il)-1H-pirazol-4-carboxílico
CN112245570A (zh) * 2019-07-22 2021-01-22 厦门特宝生物工程股份有限公司 一种基于干扰素的疾病治疗方法

Also Published As

Publication number Publication date
OA08768A (fr) 1989-03-31
GR3006999T3 (cg-RX-API-DMAC10.html) 1993-06-30
ATE83381T1 (de) 1993-01-15
EP0266940B1 (en) 1992-12-16
DE3783122D1 (de) 1993-01-28
ES2052579T3 (es) 1994-07-16
DE3783122T2 (de) 1993-04-22
EP0266940A1 (en) 1988-05-11
JPS63104929A (ja) 1988-05-10

Similar Documents

Publication Publication Date Title
Lane et al. Anti-retroviral effects of interferon-α in AIDS-associated Kaposi's sarcoma
Montefiori et al. Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay
Nair et al. Immunoregulatory effects of morphine on human lymphocytes
Mano et al. Fetal human immunodeficiency virus type 1 infection of different organs in the second trimester
Larder et al. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy
Yamamoto et al. Human alpha-and beta-interferon but not gamma-suppress the in vitro replication of LAV, HTLV-III, and ARV-2
Lee et al. Sensitive reverse transcriptase assay to detect and quantitate human immunodeficiency virus
Fauci Current issues in developing a strategy for dealing with the acquired immunodeficiency syndrome.
Wyatt et al. Persistent infection of rabbits with bovine leukemia virus associated with development of immune dysfunction
US7341731B2 (en) HIV-2 antigen compositions
Turano et al. Inhibitory effect of papaverine on HIV replication in vitro
Frumkin et al. Acute infection of Macaca nemestrina by human immunodeficiency virus type 1
DEGRÉ et al. Interferon in the serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders
Berglund et al. Combined treatment of symptomatic human immunodeficiency virus type 1 infection with native interferon-α and zidovudine
Barré-Sinoussi et al. Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDS
EP0266940B1 (en) Use of recombinant human alpha interferon for the manufacture of a medicament for the treatment of aids virus
Sherman et al. Identification of human T cell leukemia/lymphoma virus type I antibodies, DNA, and protein in patients with polymyositis
Nagashunmugam et al. Human submandibular saliva specifically inhibits HIV type 1
Fan et al. Interferon‐γ protects primary monocytes against infection with human immunodeficiency virus type 1
Preble et al. Interferon-Induced 2′–5′ Oligoadenylate Synthetase During Interferon-α Therapy in Homosexual Men with Kaposi's Sarcoma: Marked Deficiency in Biochemical Response to Interferon in Patients with Acquired Immunodeficiency Syndrome
McMinn et al. Antigenic drift of influenza A (H3N2) virus in a persistently infected immunocompromised host is similar to that occurring in the community
US5888726A (en) Pertussis toxin induced lymphocytosis
Cribier et al. Role of endogenous interferon in hepatitis C virus (HGV) infection and in coinfection by HIV and HCV
Casareale et al. Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village
Dianzani et al. Effects of IFNα on late stages of HIV-1 replication cycle

Legal Events

Date Code Title Description
MKLA Lapsed
MKEC Expiry (correction)

Effective date: 20121205